Medtech stocks fared well this year, gaining an average of nearly 45% despite headwinds including the medical device tax, the European financial crisis and an uncertain regulatory environment.
The medtech industry had a banner year in 2013, with share prices for some 39 publicly traded medical device makers rising an average 44.8% as of Dec. 17, outpacing the Dow Jones Industrial Average (up 21.1% this year), the S&P 500 (+24.9%) and the NASDAQ index (+29.8%).
Several medtech makers posted triple-digit gains this year, including Retractable Technologies (NYSE:RVP), Dexcom Inc. (NSDQ:DXCM), AtriCure (NSDQ:ATRC) and NuVasive Inc. (NSDQ:NUVA).
Retractable’s share price rose a whopping 267.9% from its 78¢ open Jan. 2, closing out Dec. 17 at $2.87. RVP share prices ranged from a low of 75¢ to a high of $4.10 during the year-to-date.
Read More: http://www.massdevice.com/news/2013-medtechs-banner-year
